The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-FTSE tracks Europe higher; Shire shines

Fri, 14th Sep 2018 17:28

* FTSE 100 up 0.3 pct

* Shire gains after China nod to Takeda deal

* Housebuilders in focus

* Investec rallies on spin-off plans(Adds closing)

By Danilo Masoni

MILAN, Sept 14 (Reuters) - Britain's top share index trackedhigher European markets on Friday with the mood buoyed by easingtrade worries, while Shire rose after China cleared Takeda'splans to buy the drugmaker.

The FTSE 100 ended up 0.3 percent, underpinned bygains among industrials and materials sectors, which more thanoffset weakness among utilities, hit earlier this week by aprofit warning from SSE.

"Traders (are) hopeful about U.S.-China trade talks despitePresident Trump being the fly in the ointment, downplayingprospects for quick negotiations," Accendo Markets analayst Mikevan Dulken said.

President Donald Trump said on Thursday that the UnitedStates was under no pressure to make a trade deal with China,even as Chinese officials welcomed an invitation from Washingtonfor a new round of talks with more U.S. tariffs looming.

After the European close, however, markets were unnervedafter a Bloomberg report said Trump had asked aides to proceedwith tariffs on $200 billion more in Chinese goods.

The FTSE scored a small weekly gain following twoconsecutive weeks of losses partly due to a rally in the poundon prospects of a Brexit deal with the European Union.

On Friday, the pound slipped after touching its highestlevel since early August. The index, whose constituents makemore than two-thirds of their sales abroad, remains down around5 percent so far in 2018.

Shire rose 2.2 percent.

Takeda Pharmaceutical said China approved itspurchase of Shire, the latest regulator to clear the $62 billiondeal and bring the Japanese group closer to becoming a globaltop 10 drugmaker.

Taked expects the deal to close in the first half of 2019although it needs shareholder approval to raise the funds to payfor the $62 billion deal.

British housebuilders Barrat Developments andTaylor Wimpey came under pressure after Bank of Englandgovernor Mark Carney was reported in the Times as having toldministers that a no-deal Brexit could cause house prices to fallby 35 percent over three years.

Their stocks recovered ground to end up 0.6 and 0.1 percentrespectively after Carney clarified that the bank's "stresstest" scenarios in which house prices fell sharply did notamount to a prediction from the BoE.

Mid-cap Investec rose 8.4 percent on news it plansto hive off and separately list its asset management unit in arestructuring that comes as the long-serving company founderleaves the financial services group.

"Investec's plan to spin off its asset management arm lookslike a sensible decision as it should allow management morefreedom to drive that business forward and not be constrained byhaving to follow the strategy of the current parent which ispredominantly a specialist banking business," said Russ Mould,investment director at AJ Bell.

JD Wetherspoon declined 1.3 percent after the pubchain said it expected higher costs this year even though arecord heatwave that brought in more customers lifted itsfull-year profit.(Reporting by Danilo Masoni;Editing by Alison Williams)

More News
4 Jan 2019 12:09

LONDON MARKET MIDDAY: Miners Keep FTSE Higher Ahead Of US Payrolls

LONDON (Alliance News) - Stocks in London remained higher midday Friday buoyed by miners, confirmed US-China trade talks and positive Chinese economic data.The FTSE 100 index was up 92.54 points,

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
5 Dec 2018 17:12

LONDON MARKET CLOSE: Stocks End Lower Amid Global Growth Fears

LONDON (Alliance News) - Stocks in London ended lower on Wednesday as concerns over global growth and trade wars continued to plague investors. The FTSE 100 index closed down 100.92 points, or at

Read more
5 Dec 2018 13:58

UPDATE: Takeda, Shire Secure Deal Approval From Shareholders

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 12:12

LONDON MARKET MIDDAY: Risk-Off Mood As Weak UK Services Adds To Worry

LONDON (Alliance News) - London stocks slid on Wednesday as risk-off sentiment replaced the more upbeat mood at start of the week, with markets in the US and Asia slumping overnight amid global of

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 08:44

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US yields

Read more
5 Dec 2018 08:40

LONDON MARKET OPEN: Stocks Sink Amid Trade War, US Economy Jitters

LONDON (Alliance News) - With Monday's gains a distant memory, the FTSE 100 shed nearly 100 points at the London open Wednesday amid renewed global trade fears and worries over the strength of

Read more
5 Dec 2018 08:00

Takeda shareholders approve £46bn Shire takeover

(Sharecast News) - Takeda Pharmaceutical shareholders have approved its £46bn takeover of London-listed pharmaceutical group Shire.

Read more
5 Dec 2018 06:58

LONDON MARKET EARLY CALL: FTSE 100 Seen Down 60 Points After NY Fall

LONDON (Alliance News) - Stocks in London are set to open sharply lower on Wednesday following a slump in New York overnight that was tracked by Asian markets, with the optimism seen at the start

Read more
5 Dec 2018 06:43

TOP NEWS: Takeda Shareholders Approve Acquisition Of Shire

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 04:06

UPDATE 1-Takeda shareholders give nod for $59 bln Shire acquisition

* Deal is the biggest overseas acquisition by Japanese firm * Some had opposed massive debt required for deal * CEO Weber has promised to slash costs (Adds details about Takashi Dec

Read more
5 Dec 2018 03:32

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a but

Read more
2 Dec 2018 11:57

Sunday newspaper round-up: US-China, Brexit, Royal Mail, Barclays, Shire

(Sharecast News) - China and the United States have agreed to halt additional tariffs as both nations engage in new trade negotiations with the goal of reaching an agreement within 90 days, the White House said on Saturday after talks between President Donald Trump and President Xi Jinping in Argentina. - Sunday Telegraph

Read more
30 Nov 2018 08:35

Shire Wins European Okay For Takhzyro Drug Ahead Of January Delisting

LONDON (Alliance News) - Shire PLC said Friday its Takhzyro injection has been approved in Europe to treat hereditary angioedema.Takhzyro is a preventative treatment for hereditary a that a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.